×
View Final Agenda PDF

Join Us in Bringing Together Top Industry, Academia & Regulatory Authorities

Join leading experts from the FDA, industry, and academia at CHI’s 17th Annual Immunogenicity & Bioassay Summit to explore the latest strategies in immunogenicity risk assessment, preclinical and clinical development, and bioassay design and analysis. Discover how to harness the immune system for therapeutic benefit through cutting-edge case studies, novel insights, and innovative approaches.

This year’s summit features:

  • Three focused conference tracks a symposium, training seminar, and five short courses
  • Interactive breakout discussions on specialized topics to foster collaboration and idea sharing
  • A dynamic exhibit and poster hall showcasing the latest products, technologies, and services

Whether you're looking to overcome challenges in immunogenicity testing or enhance your bioanalytical strategy, this summit provides the knowledge, connections, and tools to move your programs forward. We look forward to welcoming you this fall in Alexandria, VA!

Video Highlights
View Photo Gallery
Testimonials

2025 Event by the Numbers

3 Conferences
225+ Attendees
4 Short Courses
2 Training Seminars
1 Symposium

FDA Speakers to Share Key Updates

Sophie Shubow

Sophie Shubow, PhD, CDER, FDA

Yow-Ming Wang

Yow-Ming Wang, PhD, CDER, FDA

Ronit J Mazor

Ronit J Mazor, PhD, CDER, FDA

Hear From Industry and Academic Experts

Vibha Jawa

Vibha Jawa, PhD, Epivax Inc.

Alessandro Sette

Alessandro Sette, PhD, La Jolla Institute for Immunology

Amy S Rosenberg

Amy Rosenberg, MD, Regeneron Pharmaceuticals, Inc.

Piyush Vyas

Piyush Vyas, PhD, Eli Lilly & Co.

Linlin Luo

Linlin Luo, PhD Merck & Co.

Thank You to Our 2025 Corporate Sponsors

  LONZAProImmune